LLY

755.22

+3.01%↑

JNJ

153.86

-0.07%↓

UNH

378.43

-0.51%↓

ABBV

189.92

+3.08%↑

ABT

131.96

-0.98%↓

LLY

755.22

+3.01%↑

JNJ

153.86

-0.07%↓

UNH

378.43

-0.51%↓

ABBV

189.92

+3.08%↑

ABT

131.96

-0.98%↓

LLY

755.22

+3.01%↑

JNJ

153.86

-0.07%↓

UNH

378.43

-0.51%↓

ABBV

189.92

+3.08%↑

ABT

131.96

-0.98%↓

LLY

755.22

+3.01%↑

JNJ

153.86

-0.07%↓

UNH

378.43

-0.51%↓

ABBV

189.92

+3.08%↑

ABT

131.96

-0.98%↓

LLY

755.22

+3.01%↑

JNJ

153.86

-0.07%↓

UNH

378.43

-0.51%↓

ABBV

189.92

+3.08%↑

ABT

131.96

-0.98%↓

Search

Innoviva Inc

Cerrado

SectorSanidad

18.59 0.16

Resumen

Variación precio

24h

Actual

Mínimo

18.44

Máximo

18.7

Métricas clave

By Trading Economics

Ingresos

19M

20M

Ventas

2.3M

92M

P/B

Media del Sector

52.056

54.379

BPA

0.26

Margen de beneficios

22.147

Empleados

127

EBITDA

17M

36M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+196.34% upside

Dividendos

By Dow Jones

Próximas Ganancias

13 may 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

45M

1.2B

Apertura anterior

18.43

Cierre anterior

18.59

Noticias sobre sentimiento de mercado

By Acuity

50%

50%

198 / 382 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Strong Bullish Evidence

Innoviva Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

12 may 2025, 22:34 UTC

Adquisiciones, fusiones, absorciones

Ampol to Sell Retail Electricity Businesses in Australia, New Zealand

12 may 2025, 23:48 UTC

Charlas de Mercado

Gold Edges Higher on Possible Technical Recovery -- Market Talk

12 may 2025, 23:46 UTC

Charlas de Mercado

Nikkei Likely to Rise on Hopes for Improving U.S.-China Trade Relations -- Market Talk

12 may 2025, 23:34 UTC

Charlas de Mercado

Trade Deal Lowers US Recession Risks to 35% -- Market Talk

12 may 2025, 23:21 UTC

Charlas de Mercado

US-China Trade Deal Still Risks Stagflation; Supply Chain Disruption -- Market Talk

12 may 2025, 22:54 UTC

Charlas de Mercado

Australian Treasurer Warns Uncertainty Will Still Dominate Markets -- Market Talk

12 may 2025, 22:43 UTC

Ganancias

Telefonica Brasil 1Q EPS BRL0.65 >VIV

12 may 2025, 22:14 UTC

Principales Noticias

Drugmakers Spared Worst-Case Drug Pricing Scenario for Now -- 2nd Update

12 may 2025, 22:08 UTC

Adquisiciones, fusiones, absorciones

Ampol Expects Replacement-Cost Ebitda Uplift by Run Rate at End-2025 of Around A$30 Million/Year

12 may 2025, 22:08 UTC

Adquisiciones, fusiones, absorciones

Ampol Expects Pretax Proceeds of Around A$65 Million From Transactions

12 may 2025, 22:07 UTC

Adquisiciones, fusiones, absorciones

Ampol to Sell Australia Retail Electricity Business for Nominal Sum

12 may 2025, 22:07 UTC

Adquisiciones, fusiones, absorciones

Ampol to Sell Australia Retail Electricity Business to AGL

12 may 2025, 22:06 UTC

Adquisiciones, fusiones, absorciones

Meridian to Take on Flick, Z Energy Branded Electricity Customers

12 may 2025, 22:06 UTC

Adquisiciones, fusiones, absorciones

Meridian Energy to Buy Business From Ampol for NZ$70 Million

12 may 2025, 22:05 UTC

Adquisiciones, fusiones, absorciones

Ampol to Sell New Zealand Electricity Retailing Businesses to Meridian Energy

12 may 2025, 22:04 UTC

Adquisiciones, fusiones, absorciones

Ampol to Sell Retail Electricity Businesses in Australia, New Zealand

12 may 2025, 21:15 UTC

Principales Noticias

Republican Tax Plan Boosts SALT Deduction, Ends Green-Energy Breaks -- 2nd update -- WSJ

12 may 2025, 21:01 UTC

Ganancias

Constellation Software 1Q Rev $2.65B >CSU.T

12 may 2025, 21:01 UTC

Ganancias

Constellation Software 1Q Net $115M >CSU.T

12 may 2025, 21:01 UTC

Ganancias

Constellation Software 1Q EPS $5.44 >CSU.T

12 may 2025, 20:50 UTC

Charlas de Mercado

Financial Services Roundup: Market Talk

12 may 2025, 20:50 UTC

Charlas de Mercado
Ganancias

Basic Materials Roundup: Market Talk

12 may 2025, 20:44 UTC

Principales Noticias

Trade Thaw Sparks Stock Rally, Leaves Wall Street Cautious -- WSJ

12 may 2025, 20:31 UTC

Principales Noticias

How to Think About the Stock Market When Earnings Guidance Becomes Meaningless -- Heard on the Street -- UPDATED -- WSJ

12 may 2025, 20:24 UTC

Ganancias

Energy Vault Holdings: Encouraging News on China/U.S. Tariff Pause, Pending Final Positive Resolution and Timing >NRGV

12 may 2025, 20:24 UTC

Ganancias

Energy Vault Holdings: No Change to Current Guidance, With Potential Rev Upside on Accelerated U.S. Battery Deliveries in 2025 >NRGV

12 may 2025, 20:24 UTC

Principales Noticias

Republican Tax Plan Boosts SALT Deduction, Ends Green-Energy Breaks -- WSJ

12 may 2025, 20:22 UTC

Adquisiciones, fusiones, absorciones

Spirit AeroSystems Holdings: IRS Rules That Sale to Boeing Will Qualify as a Reorganization Under Section 368(a)(1)(B)

12 may 2025, 20:15 UTC

Ganancias

Rigetti Computing Reports Earnings. How the Company Takes a Different Approach to Quantum. -- Barrons.com

12 may 2025, 20:10 UTC

Ganancias

Blink Charging 1Q Rev $20.8M >BLNK

Comparación entre iguales

Cambio de precio

Innoviva Inc previsión

Precio Objetivo

By TipRanks

196.34% repunte

Estimación a 12 Meses

Media 55 USD  196.34%

Máximo 55 USD

Mínimo 55 USD

De acuerdo con 1 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Innoviva Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

1 ratings

1

Comprar

0

Mantener

0

Vender

Puntuación técnica

By Trading Central

18.57 / 18.75Soporte y Resistencia

Corto Plazo

Strong Bullish Evidence

Medio plazo

Weak Bullish Evidence

Largo Plazo

Neutral Evidence

Sentimiento

By Acuity

198 / 382 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Neutral

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Innoviva Inc

Innoviva, Inc. engages in the development and commercialization of pharmaceutical products in the United States and internationally. The company's products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA) and umeclidinium bromide (UMEC) with a LABA, VI; GIAPREZA (angiotensin II), a vasoconstrictor to increase blood pressure in adults with septic or other distributive shock; XERAVA (eravacycline) for the treatment of complicated intra-abdominal infections in adults; and XACDURO, a beta lactamase inhibitor for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia. Its development pipeline includes zoliflodacin, a late-stage product candidate, a potential single oral dose cure for the treatment of uncomplicated gonorrhea. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. It has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.